Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Olaparib Impurity 49 REF: 4Z-O-032054	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 26 REF: 4Z-N-066042	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 18 REF: 4Z-G-047021	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 12 HCl REF: 4Z-B-119015	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 43 REF: 4Z-E-068056CAS: 392-09-6	- - -	To inquire	Tue 10 Dec 24
Abiraterone Impurity 31 REF: 4Z-A-8281CAS: 23930-63-4	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 75 REF: 4Z-O-032081CAS: 1062292-60-7	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 33 REF: 4Z-C-121036CAS: 247068-81-1	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 8 REF: 4Z-F-3130	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 46 REF: 4Z-N-066064	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 37 REF: 4Z-E-068050	- - -	To inquire	Tue 10 Dec 24
Lenvatinib Impurity 56 REF: 4Z-L-124063	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 51 REF: 4Z-O-032056	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 68 REF: 4Z-P-196075CAS: 1023594-49-1	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 80 REF: 4Z-N-066091CAS: 262368-25-2	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 43 REF: 4Z-O-032048CAS: 42086-73-7	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 3 REF: 4Z-E-068011	- - -	To inquire	Tue 10 Dec 24
Bestatin Impurity 10 REF: 4Z-B-119013CAS: 538-75-0	- - -	To inquire	Tue 10 Dec 24
Fulvestrant Impurity 15 REF: 4Z-F-3123	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 81 Sodium Salt REF: 4Z-O-032088	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Olaparib Impurity 49

Ref: 4Z-O-032054

Nintedanib Impurity 26

Ref: 4Z-N-066042

Gimeracil Impurity 18

Ref: 4Z-G-047021

Bestatin Impurity 12 HCl

Ref: 4Z-B-119015

Enzalutamide Impurity 43

Ref: 4Z-E-068056

Abiraterone Impurity 31

Ref: 4Z-A-8281

Olaparib Impurity 75

Ref: 4Z-O-032081

Carfilzomib Impurity 33

Ref: 4Z-C-121036

Fulvestrant Impurity 8

Ref: 4Z-F-3130

Nintedanib Impurity 46

Ref: 4Z-N-066064

Enzalutamide Impurity 37

Ref: 4Z-E-068050

Lenvatinib Impurity 56

Ref: 4Z-L-124063

Olaparib Impurity 51

Ref: 4Z-O-032056

Palbociclib Impurity 68

Ref: 4Z-P-196075

Nintedanib Impurity 80

Ref: 4Z-N-066091

Olaparib Impurity 43

Ref: 4Z-O-032048

Enzalutamide Impurity 3

Ref: 4Z-E-068011

Bestatin Impurity 10

Ref: 4Z-B-119013

Fulvestrant Impurity 15

Ref: 4Z-F-3123

Olaparib Impurity 81 Sodium Salt

Ref: 4Z-O-032088